← All trials
NCT05721235
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 24, 2023
- Primary completion
- Mar 30, 2025
- Completion date
- Mar 30, 2025
- First posted
- Feb 9, 2023
- Last posted
- May 26, 2023
- Enrollment
- 100
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Corium International Inc.Lead sponsor
- Worldwide Clinical TrialsCollaborator
- Premier Research GroupCollaborator
- Almac Clinical Services LLCCollaborator
- Center for Psychiatry And Behavioral Medicine Inc.Overall official - principal investigator
- Prometrika, LLCCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.